Literature DB >> 27912058

Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder.

Dora C Tărlungeanu1, Elena Deliu1, Christoph P Dotter1, Majdi Kara2, Philipp Christoph Janiesch3, Mariafrancesca Scalise4, Michele Galluccio4, Mateja Tesulov1, Emanuela Morelli1, Fatma Mujgan Sonmez5, Kaya Bilguvar6, Ryuichi Ohgaki7, Yoshikatsu Kanai7, Anide Johansen8, Seham Esharif2, Tawfeg Ben-Omran9, Meral Topcu10, Avner Schlessinger11, Cesare Indiveri4, Kent E Duncan3, Ahmet Okay Caglayan12, Murat Gunel13, Joseph G Gleeson8, Gaia Novarino14.   

Abstract

Autism spectrum disorders (ASD) are a group of genetic disorders often overlapping with other neurological conditions. We previously described abnormalities in the branched-chain amino acid (BCAA) catabolic pathway as a cause of ASD. Here, we show that the solute carrier transporter 7a5 (SLC7A5), a large neutral amino acid transporter localized at the blood brain barrier (BBB), has an essential role in maintaining normal levels of brain BCAAs. In mice, deletion of Slc7a5 from the endothelial cells of the BBB leads to atypical brain amino acid profile, abnormal mRNA translation, and severe neurological abnormalities. Furthermore, we identified several patients with autistic traits and motor delay carrying deleterious homozygous mutations in the SLC7A5 gene. Finally, we demonstrate that BCAA intracerebroventricular administration ameliorates abnormal behaviors in adult mutant mice. Our data elucidate a neurological syndrome defined by SLC7A5 mutations and support an essential role for the BCAA in human brain function. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASD; amino acid transporter; autism; blood brain barrier; excitation and inhibition imbalance; motor deficits

Mesh:

Substances:

Year:  2016        PMID: 27912058      PMCID: PMC5554935          DOI: 10.1016/j.cell.2016.11.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  34 in total

Review 1.  System L: heteromeric exchangers of large, neutral amino acids involved in directional transport.

Authors:  François Verrey
Journal:  Pflugers Arch       Date:  2002-11-21       Impact factor: 3.657

2.  Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons.

Authors:  James M Angelastro; Tatyana N Ignatova; Valery G Kukekov; Dennis A Steindler; George B Stengren; Cathy Mendelsohn; Lloyd A Greene
Journal:  J Neurosci       Date:  2003-06-01       Impact factor: 6.167

3.  LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter.

Authors:  Lara Napolitano; Mariafrancesca Scalise; Michele Galluccio; Lorena Pochini; Leticia Maria Albanese; Cesare Indiveri
Journal:  Int J Biochem Cell Biol       Date:  2015-08-06       Impact factor: 5.085

Review 4.  The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders.

Authors:  Sien Braat; R Frank Kooy
Journal:  Neuron       Date:  2015-06-03       Impact factor: 17.173

5.  Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.

Authors:  Ethan G Geier; Avner Schlessinger; Hao Fan; Jonathan E Gable; John J Irwin; Andrej Sali; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 6.  ATF4-dependent transcription mediates signaling of amino acid limitation.

Authors:  Michael S Kilberg; Jixiu Shan; Nan Su
Journal:  Trends Endocrinol Metab       Date:  2009-09-30       Impact factor: 12.015

7.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.

Authors:  L Mastroberardino; B Spindler; R Pfeiffer; P J Skelly; J Loffing; C B Shoemaker; F Verrey
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

8.  Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy.

Authors:  Gaia Novarino; Paul El-Fishawy; Hulya Kayserili; Nagwa A Meguid; Eric M Scott; Jana Schroth; Jennifer L Silhavy; Majdi Kara; Rehab O Khalil; Tawfeg Ben-Omran; A Gulhan Ercan-Sencicek; Adel F Hashish; Stephan J Sanders; Abha R Gupta; Hebatalla S Hashem; Dietrich Matern; Stacey Gabriel; Larry Sweetman; Yasmeen Rahimi; Robert A Harris; Matthew W State; Joseph G Gleeson
Journal:  Science       Date:  2012-09-06       Impact factor: 47.728

9.  Synaptic, transcriptional and chromatin genes disrupted in autism.

Authors:  Silvia De Rubeis; Xin He; Arthur P Goldberg; Christopher S Poultney; Kaitlin Samocha; A Erucment Cicek; Yan Kou; Li Liu; Menachem Fromer; Susan Walker; Tarinder Singh; Lambertus Klei; Jack Kosmicki; Fu Shih-Chen; Branko Aleksic; Monica Biscaldi; Patrick F Bolton; Jessica M Brownfeld; Jinlu Cai; Nicholas G Campbell; Angel Carracedo; Maria H Chahrour; Andreas G Chiocchetti; Hilary Coon; Emily L Crawford; Sarah R Curran; Geraldine Dawson; Eftichia Duketis; Bridget A Fernandez; Louise Gallagher; Evan Geller; Stephen J Guter; R Sean Hill; Juliana Ionita-Laza; Patricia Jimenz Gonzalez; Helena Kilpinen; Sabine M Klauck; Alexander Kolevzon; Irene Lee; Irene Lei; Jing Lei; Terho Lehtimäki; Chiao-Feng Lin; Avi Ma'ayan; Christian R Marshall; Alison L McInnes; Benjamin Neale; Michael J Owen; Noriio Ozaki; Mara Parellada; Jeremy R Parr; Shaun Purcell; Kaija Puura; Deepthi Rajagopalan; Karola Rehnström; Abraham Reichenberg; Aniko Sabo; Michael Sachse; Stephan J Sanders; Chad Schafer; Martin Schulte-Rüther; David Skuse; Christine Stevens; Peter Szatmari; Kristiina Tammimies; Otto Valladares; Annette Voran; Wang Li-San; Lauren A Weiss; A Jeremy Willsey; Timothy W Yu; Ryan K C Yuen; Edwin H Cook; Christine M Freitag; Michael Gill; Christina M Hultman; Thomas Lehner; Aaarno Palotie; Gerard D Schellenberg; Pamela Sklar; Matthew W State; James S Sutcliffe; Christiopher A Walsh; Stephen W Scherer; Michael E Zwick; Jeffrey C Barett; David J Cutler; Kathryn Roeder; Bernie Devlin; Mark J Daly; Joseph D Buxbaum
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

10.  Exaggerated translation causes synaptic and behavioural aberrations associated with autism.

Authors:  Emanuela Santini; Thu N Huynh; Andrew F MacAskill; Adam G Carter; Philippe Pierre; Davide Ruggero; Hanoch Kaphzan; Eric Klann
Journal:  Nature       Date:  2012-12-23       Impact factor: 49.962

View more
  95 in total

Review 1.  Vascular heterogeneity and specialization in development and disease.

Authors:  Michael Potente; Taija Mäkinen
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-24       Impact factor: 94.444

Review 2.  The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.

Authors:  Mohd Omar F Sikder; Shengping Yang; Vadivel Ganapathy; Yangzom D Bhutia
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

Review 3.  Organ-specific protection mediated by cooperation between vascular and epithelial barriers.

Authors:  Ilaria Spadoni; Giulia Fornasa; Maria Rescigno
Journal:  Nat Rev Immunol       Date:  2017-09-04       Impact factor: 53.106

Review 4.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

5.  Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.

Authors:  Alan M Smith; Joseph J King; Paul R West; Michael A Ludwig; Elizabeth L R Donley; Robert E Burrier; David G Amaral
Journal:  Biol Psychiatry       Date:  2018-09-06       Impact factor: 13.382

6.  In Vitro Models of the Blood-Brain Barrier.

Authors:  Winfried Neuhaus
Journal:  Handb Exp Pharmacol       Date:  2021

7.  The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.

Authors:  Kakeru Ozaki; Takanori Yamada; Tetsuhiro Horie; Atsushi Ishizaki; Manami Hiraiwa; Takashi Iezaki; Gyujin Park; Kazuya Fukasawa; Hikari Kamada; Kazuya Tokumura; Mei Motono; Katsuyuki Kaneda; Kazuma Ogawa; Hiroki Ochi; Shingo Sato; Yasuhiro Kobayashi; Yun-Bo Shi; Peter M Taylor; Eiichi Hinoi
Journal:  Sci Signal       Date:  2019-07-09       Impact factor: 8.192

Review 8.  TOR Signaling in Caenorhabditis elegans Development, Metabolism, and Aging.

Authors:  T Keith Blackwell; Aileen K Sewell; Ziyun Wu; Min Han
Journal:  Genetics       Date:  2019-10       Impact factor: 4.562

9.  Branched Chain Amino Acids.

Authors:  Michael Neinast; Danielle Murashige; Zoltan Arany
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.